ArticleTranslational cancer research2020

Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab.

Yasuhiro Chikaishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.